Loading news...
Bioceres Crop Solutions Corp. (NASDAQ: BIOX - Get Free Report) saw a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 942,815 shares, a growth of 71.0% from the January 29th total of 551,455 shares. Approximately 1.5% of the company's shares are sold short. Based on
Bioceres Crop Solutions Corp. (NASDAQ: BIOX - Get Free Report) has earned a consensus recommendation of "Hold" from the five analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company.
Bioceres Crop Solutions Corp. (BIOX) Shareholder/Analyst Call Prepared Remarks Transcript
Bioceres Crop Solutions Corp. (NASDAQ: BIOX - Get Free Report) has received a consensus recommendation of "Hold" from the five research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and one has assigned a buy recommendation to the company.
Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) and Brasilagro Cia Brasileira De Propriedades Agricolas (NYSE: LND - Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Earnings
Shares of Bioceres Crop Solutions Corp. (NASDAQ: BIOX - Get Free Report) have been assigned an average recommendation of "Hold" from the five analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy
Bioceres reported 1Q26 results with continued revenue declines but improved gross margins and significant OpEx reductions, boosting profitability. BIOX faces severe financial risks, including default claims and lawsuits to accelerate over $100 million in debt, which it cannot cover with current cash. Equity holders face high dilution risk from convertible notes and potential asset sales, as the company cannot be evaluated as a going concern.
Bioceres Crop Solutions Corp. ( BIOX ) Q1 2026 Earnings Call November 13, 2025 8:30 AM EST Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Austin Moeller - Canaccord Genuity Corp., Research Division Presentation Operator Good morning all, and thank you for joining us on today's Bioceres Crop Solutions Fiscal First Quarter 2026 Financial and Operational Results. My name is Drew, and I'll be the operator on the call today.
Bioceres Crop (BIOX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.09 per share a year ago.
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons.
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2025. A press release detailing these results will be.
ROSARIO, Argentina & FORT COLLINS, Colorado--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) and the Colorado Wheat Research Foundation (CWRF) today announced a strategic collaboration to jointly develop and commercialize HB4® wheat in the United States. The agreement combines Bioceres' proprietary HB4® technology, with CWRF's leadership in U.S. wheat innovation to create a next generation wheat production system. This system is designed to integrate climate resilience and environ.
Bioceres reported a disastrous year with sales down 30%, margins collapsing, and large unexplained debt losses, resulting in a $60 million net loss. The company faces severe liquidity and capital allocation risks, with high-interest debt, unclear disclosures, and increased dilution risk from convertible notes. Management and board instability, along with poor reporting transparency, further undermine confidence in Bioceres' ability to navigate its challenges.
Downgrade Bioceres Crop Solutions Corp. to Hold due to Argentina's volatile currency, credit constraints, and a challenging shift in the seed sales model. Recent results show sharply lower revenues, deeper losses, but disciplined cash management, and a focus on cost reductions going forward. Valuation sits at 3.5x gross profit and 8.5–11x EV/EBITDA, but earnings risk and potential dilution remain high.
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2025 Earnings Call September 9, 2025 8:30 AM EDT Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Kristen Owen - Oppenheimer & Co. Inc., Research Division Benjamin Klieve - Lake Street Capital Markets, LLC, Research Division Austin Moeller - Canaccord Genuity Corp., Research Division Brian Kemp Dolliver - Brookline Capital Markets, LLC, Research Division Presentation Operator Welcome all to the Bioceres Crop Solutions Fiscal Fourth Quarter and Full Year 2025 Financial Results. My name is Drew, and I'll be the operator on the call today.
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, today announced changes to the composition of its Board of Directors. Noah Kolatch and Scott Crocco are being appointed to the Company's Board of Directors with effect from June 24, 2025. Noah Kolatch is a Principal at Jaspe.
Bioceres faces mounting financial stress, with Argentina's weak agriculture sector and loss of Syngenta payments driving revenue and EBITDA declines. Cash flow is tightening rapidly; asset sales and one-off inventory benefits are masking underlying losses, while debt and interest costs loom large. Long-term product developments like HB4 and RINO offer potential, but have yet to deliver meaningful, scalable revenue or margin improvements.
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q3 2025 Results Conference Call May 21, 2025 8:30 AM ET Company Participants Paula Savanti - Head, Investor Relations Federico Trucco - Chief Executive Officer Enrique López Lecube - Chief Financial Officer Milen Marinov - Chief Commercial Officer Conference Call Participants Kristen Owen - Oppenheimer Ben Klieve - Lake Street Capital Markets Austin Moeller - Canaccord Steve Byrne - Bank of America Kemp Dolliver - Brookline Capital Markets Operator Hello, everyone, and thank you for joining us on today's Bioceres Crop Solutions Fiscal Third Quarter 2025 Financial and Operational Results. My name is Drew and I'll be the operator on today's call.